In brief

The R&D Tax Credit offers a direct reduction to companies’ prior, current, and future federal and state income tax liabilities.
Specifically, the R&D Tax Credit aims to reward a wide variety of American businesses that engage in qualified research activities per IRS criteria

ELIGIBLE BIOTECH & LIFESCIENCES R&D ACTIVITIES

Including, but not limited to:

  • Development of new or improved pharmaceuticals,
    medical devices, or biologics
  • Reformulating drugs to increase quality (i.e. longer
    shelf life, less side effects)
  • Development and testing of hardware and software
    systems used in clinical research
  • Development of new or improved medical
    compounds, biologics, or therapies
  • Developing new production and manufacturing
    processes

ELIGIBLE BIOTECH & LIFESCIENCES QUALIFIED EXPENSES

Including, but not limited to:

Employee Wages

  • Lab Technician
  • Lab Manager
  • Chemist
  • Product/Process Engineer
  • Quality Assurance

Supplies

  • Chemical Compounds
  • Ingredients / Formulations
  • Testing Materials

Subcontractors

  • CROs, Outside testing

Why choose EPSA USA?

EPSA USA helps companies of all sizes take full advantage of the Research & Development Tax Credit. EPSA’s technical experts follow strict IRS guidelines and identify qualified research expenditures that dictate eligibility.

We work hand-in-hand with our clients to offer tailored solutions to maximize your R&D Tax Credits. Our streamlined process is efficient, fast and guaranteed to optimize your tax benefits.

With 30 offices in 15 countries and over 300 experts in various domains, EPSA possesses precise technical and scientific knowledge spanning all types of industries.

Our services

R&D Tax Credit

R&D State Credit

174 Amortization

Global Incentive Programs

Grants & Subsidies